- Home
- ICLR vs BALL Comparison
ICLR vs BALL Comparison
Compare ICLR & BALL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- BALL
- Stock Information
- Founded
- ICLR 1990
- BALL 1880
- Country
- ICLR Ireland
- BALL United States
- Employees
- ICLR N/A
- BALL N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- BALL Containers/Packaging
- Sector
- ICLR Health Care
- BALL Industrials
- Exchange
- ICLR Nasdaq
- BALL Nasdaq
- Market Cap
- ICLR 14.3B
- BALL 12.8B
- IPO Year
- ICLR 1998
- BALL N/A
- Fundamental
- Price
- ICLR $162.73
- BALL $47.63
- Analyst Decision
- ICLR Buy
- BALL Buy
- Analyst Count
- ICLR 15
- BALL 13
- Target Price
- ICLR $205.07
- BALL $62.17
- AVG Volume (30 Days)
- ICLR 963.3K
- BALL 3.2M
- Earning Date
- ICLR 10-22-2025
- BALL 11-04-2025
- Dividend Yield
- ICLR N/A
- BALL 1.68%
- EPS Growth
- ICLR N/A
- BALL N/A
- EPS
- ICLR 7.47
- BALL 2.40
- Revenue
- ICLR $8,102,602,000.00
- BALL $12,694,000,000.00
- Revenue This Year
- ICLR N/A
- BALL $10.84
- Revenue Next Year
- ICLR $0.89
- BALL $3.21
- P/E Ratio
- ICLR $21.70
- BALL $18.97
- Revenue Growth
- ICLR N/A
- BALL 7.41
- 52 Week Low
- ICLR $125.10
- BALL $43.51
- 52 Week High
- ICLR $228.29
- BALL $63.35
- Technical
- Relative Strength Index (RSI)
- ICLR 40.46
- BALL 46.56
- Support Level
- ICLR $155.00
- BALL $46.41
- Resistance Level
- ICLR $167.43
- BALL $48.27
- Average True Range (ATR)
- ICLR 6.33
- BALL 1.41
- MACD
- ICLR -0.64
- BALL 0.00
- Stochastic Oscillator
- ICLR 30.91
- BALL 56.29
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About BALL Ball Corporation
Ball is the world's largest metal can manufacturer with market share over 30% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments—beverage packaging, North and Central America (48% of 2024 revenue), beverage packaging, EMEA (29%), beverage packaging, South America (17%)—and it generated $12 billion in revenue in 2024.